Point of Care Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy and Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Hematology Testing Products, and Other POC Products), Prescription Mode (Prescription-Based Testing and OTC Testing), and End User (Professional Diagnostic Centers, Home Care, Research Laboratories, and Others), and Geography
Publication Month: Jun 2021 | Report Code: TIPRE00006394 | No. of Pages: 245 | Category: Medical Device | Status: Published
The point of care diagnostics market was valued at US$ 36,000.4 million in 2021 and is projected to reach US$ 82,958.3 million by 2028; it is expected to grow at a CAGR of 12.7% from 2021 to 2028.
Point of care testing (POCT) is described as medical diagnostic testing at or near the point of care that is, at time and place of patient care. The purpose of POCT is to provide immediate information to physicians about the patient's condition. POCT is an important diagnostic tool used in various locations in the hospital such as the intensive care unit (ICU), the operating room (OR), and the emergency department (ED). The market growth is primarily attributed to increase in prevalence of infectious diseases, product developments and launches, and rise in number of CLIA-waived POC tests. However, product recalls are expected to hamper the market growth.
The point of care diagnostics market is witnessing substantial growth amid the COVID-19 pandemic. Certain factors such as sudden rise in coronavirus infections and exponential growth in COVID-19 diagnostic kits played a prominent role in the growth of the point of care diagnostics market during the pandemic. In addition, the growing demand for rapid test kits for faster diagnosis at public places is also estimated to have positive impact on the market growth.
Lucrative Regions for Point of Care Diagnostics Market
Get more information on this report :
Market Insights
Product Developments and Launches to Fuel Point of Care Diagnostics Market Growth
The use of point of care testing has steadily increased over the last 40 years since its widespread introduction. The point of care diagnostics market is likely to grow with the introduction of new products into the market, aimed at delivering inexpensive care at the facilities located at the closest-possible distances from the patients’ location. New technologies or products are being refined and improved to deliver easier to use devices with incremental improvements in analytical performance.
The growth of the POC market is mainly attributed to the introduction of new devices to perform molecular testing. Many new devices have been launched in recent years. For instance, in June 2019, Abbott launched first-ever rapid POC HbA1c test to aid in the diagnosis of diabetes; this test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation. Moreover, in July 2021, BD announced launch of rapid and portable point-of-care antigen test for diagnosis of COVID-19. The new test kit is capable to deliver results within 15 minutes of the test. Besides, in December 2020, Beckman Coulter also introduced its rapid antigen kit for diagnosis of COVID-19. Similarly, in 2017, Roche Diagnostic division launched CoaguChek Vantus PoC in the US; this system enables handheld coagulation monitoring system for the self-assessment of health. The division has also launched new point-of-care mobile application—Cobas Infinity—designed to meet the needs of point-of-care coordinators to manage important tasks on the go. Such advancements in new launched devices will propel the overall POC market growth during the forecast period.
Point of Care Diagnostics Market, by Product – 2021 and 2028
Get more information on this report :
Product-Based Insights
Based on product, the point of care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker testing, cholesterol testing, urinalysis testing, hematology testing, and other POC products. The infectious diseases segment is further subsegmented into HIV testing, influenza testing, sexually transmitted disease (STD) testing, hepatitis c testing, healthcare-associated infection (HAI) testing, tropical disease testing, respiratory infection testing, and other infectious disease testing. In 2020, the glucose monitoring segment held the largest share of the market. However, the infectious diseases segment is estimated to register the highest CAGR during the forecast period.
Prescription Mode-Based Insights
Based on prescription mode, the point of care diagnostics market is bifurcated into prescription-based testing and OTC testing. In 2020, the prescription-based testing segment held a larger share of the market and is expected to register a higher CAGR during the forecast period. The growth of this segment is mainly attributed to the increase in incidence and prevalence of lifestyle diseases and the lack of awareness about OTC POCT devices in developing nations.
End User-Based Insights
In terms of end user, the point of care diagnostics market is segmented into professional diagnostic centers, home care, research laboratories, and others. In 2020, the professional diagnostic centers segment held a substantial market share. The professional diagnostic centers segment is further subsegmented into hospitals, clinical laboratories, outpatient healthcare, and ambulatory care settings. However, the home care segment is expected to register the highest CAGR during the forecast period.
Strategic Insights
The point of care diagnostics market players are adopting the product launch and expansion strategies to meet changing customer demands, which further allows them to maintain their brand name globally.
Point of Care Diagnostics Market – by Product
- Glucose Monitoring
- Infectious Disease Testing
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing
- Pregnancy and Fertility Testing
- Coagulation Testing
- Tumor/Cancer Marker Testing
- Cholesterol Testing
- Urinalysis Testing
- Hematology Testing
- Other POC Products
Point of Care Diagnostics Market – by Prescription Mode
- Prescription-Based Testing
- OTC Testing
Point of Care Diagnostics Market – by End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
Point of Care Diagnostics Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
- South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- F. HOFFMANN-LA ROCHE LTD.
- Danaher
- BIO-RAD LABORATORIES INC.
- Abbott
- Johnson and Johnson Services, Inc.
- Siemens AG
- BD
- BioMerieux SA
- Polymer Technology Systems, Inc. (PTS)
- Nova Biomedical
The List of Companies - Point of Care Diagnostics Market
- F. Hoffmann-La Roche Ltd
- Abbott
- bioMérieux SA
- Johnson & Johnson Services, Inc.
- Nova Biomedical
- Siemens AG
- Bio Rad Laboratories Inc.
- BD
- Danaher Corporation
- PTS Diagnostics
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Point of Care Diagnostics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global Point of Care Diagnostics Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000 $2700
$4550 $4095$6550 $5568$8550 $6840Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount
